Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2000 Feb;44(2):473-4.
doi: 10.1128/AAC.44.2.473-474.2000.

May the drug transporter P glycoprotein affect the antiviral activity of human immunodeficiency virus type 1 proteinase inhibitors?

O Turriziani, P Di Marco, G Antonelli, F Dianzani
Comment

May the drug transporter P glycoprotein affect the antiviral activity of human immunodeficiency virus type 1 proteinase inhibitors?

O Turriziani et al. Antimicrob Agents Chemother. 2000 Feb.
No abstract available

PubMed Disclaimer

Figures

FIG. 1
FIG. 1
Antiviral activities of saquinavir and indinavir in CEM and CEMVBL100 cells in the presence or absence of verapamil (2 μM). Cells of both types were infected with HIVpnl43 at a multiplicity of infection of 0.1. After 5 days of incubation, percent viral-yield reduction was determined by measuring the level of p24 antigen. Data are means with standard deviations for three independent experiments.
See this image and copyright information in PMC

Comment on

References

    1. Cole S P, Deeley R G. Multidrug resistance associated with overexpression of MRP. Cancer Treat Res. 1996;87:39–61. - PubMed
    1. Kim R B, From M F, Wandel C, Leake B, Wood A J J, Roden D M. The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 proteinase inhibitors. J Clin Invest. 1998;101:289–294. - PMC - PubMed
    1. Lee C G L, Gottesman M M, Cardarelli C O, Ramachandra R, Jeang K, Ambudkar S V, Pastan I, Dey S. HIV-1 protease inhibitors are substrates for the MDR1 multidrug transporter. Biochemistry. 1998;37:3594–3601. - PubMed
    1. Srinivas R V, Middlemas D, Flynn P, Fridland a. Human immunodeficiecy cirus protease inhibitors serve as substrates for multidrug transporter proteins MDR1 and NRP1 but retain antibiral efficacy in cell lines expressing these transporters. Antimicrob Agents Chemother. 1998;42:3157–3162. - PMC - PubMed
    1. Washington C B, Duran G E, Man M C, Sikic B I, Blaschke T F. Interaction of anti-HIV proteinase inhibitors with the multidrug transporter P-glycoprotein (P-gp) in human cultured cells. J Acquired Immune Defic Syndr Human Retrovirol. 1998;19:203–209. - PubMed

MeSH terms

Substances

LinkOut - more resources